Patents by Inventor William D. Rapp

William D. Rapp has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9090882
    Abstract: Threonine is an essential amino acid for humans and in the animal feed industry where its levels in feed rations can significantly impact the cost of production of important meat sources, such as swine and poultry. Threonine as well as essential amino acids lysine and methionine are all synthesized via the aspartate family pathway. Aspartate kinase (AK) is the first enzyme in the pathway, and catalyzes the ATP-dependent phosphorylation of aspartate to form ?-aspartyl phosphate. AK constitutes the main regulatory step controlling the metabolic flux through the pathway, and is subject to end product inhibition by Lys and/or Thr. The current invention provides a method to produce a transgenic high free threonine soybean via the overexpression of feedback-resistant AK enzymes in developing soybean plants and seeds. These modifications provide a method to enhance both plant nitrogen metabolism and crop growth performance.
    Type: Grant
    Filed: June 30, 2009
    Date of Patent: July 28, 2015
    Assignee: Monsanto Technology LLC
    Inventors: James H. Crowley, Barry S. Goldman, Jintai Huang, Qungang Qi, William D. Rapp
  • Patent number: 8981188
    Abstract: Novel expression vectors and constructs encoding a chloroplast transit peptide (CTP) operably linked to a monomeric anthranilate synthase are provided. Additionally, novel polynucleotide sequences encoding monomeric anthranilate synthases are provided. Also provided are methods for increasing the levels of free tryptophan in transgenic plants containing the expression vectors and constructs.
    Type: Grant
    Filed: March 20, 2012
    Date of Patent: March 17, 2015
    Assignee: Monsanto Technology LLC
    Inventors: Siva Manjunath, Santiago Xavier Navarro, William D. Rapp, Xiaohong Shi, Marguerite J. Varagona, Jennifer L. Winson, Guangning Ye
  • Publication number: 20120246762
    Abstract: Novel expression vectors and constructs encoding a chloroplast transit peptide (CTP) operably linked to a monomeric anthranilate synthase are provided. Additionally, novel polynucleotide sequences encoding monomeric anthranilate synthases are provided. Also provided are methods for increasing the levels of free tryptophan in transgenic plants containing the expression vectors and constructs.
    Type: Application
    Filed: March 20, 2012
    Publication date: September 27, 2012
    Inventors: Siva Manjunath, Santiago Xavier Navarro, William D. Rapp, Xiaohong Shi, Marguerite J. Varagona, Jennifer L. Winson, Guangning Ye
  • Patent number: 8138393
    Abstract: Novel expression vectors and constructs encoding a chloroplast transit peptide (CTP) operably linked to a monomeric anthranilate synthase are provided. Additionally, novel polynucleotide sequences encoding monomeric anthranilate synthases are provided. Also provided are methods for increasing the levels of free tryptophan in transgenic plants containing the expression vectors and constructs.
    Type: Grant
    Filed: August 9, 2007
    Date of Patent: March 20, 2012
    Assignee: Monsanto Technology LLC
    Inventors: Siva Manjunath, Santiago Xavier Navarro, William D. Rapp, Xiaohong Shi, Marguerite J. Varagona, Jennifer L. Winson, Guangning Ye
  • Patent number: 6936696
    Abstract: The present invention generally relates to the field of plant genetics and protein biochemistry. More specifically, the present invention relates to modified proteins having an increased number of essential amino acids. The invention provides proteins modified to have an increased number of essential amino acids, nucleic acid sequences encoding the enhanced proteins, and methods of designing, producing, and using the same. The invention also includes compositions, transformed host cells, transgenic plants and seeds containing the enhanced proteins, and methods for preparing and using the same.
    Type: Grant
    Filed: September 17, 2002
    Date of Patent: August 30, 2005
    Assignee: Monsanto Company
    Inventors: William D. Rapp, Jiexin Peng, Gautham Nadig, Tyamagondlu Venkatesh
  • Publication number: 20030200558
    Abstract: The present invention generally relates to the field of plant genetics and protein biochemistry. More specifically, the present invention relates to modified proteins having an increased number of essential amino acids. The invention provides proteins modified to have an increased number of essential amino acids, nucleic acid sequences encoding the enhanced proteins, and methods of designing, producing, and using the same. The invention also includes compositions, transformed host cells, transgenic plants and seeds containing the enhanced proteins, and methods for preparing and using the same.
    Type: Application
    Filed: September 17, 2002
    Publication date: October 23, 2003
    Inventors: William D. Rapp, Jiexin Peng, Gautham Nadig, Tyamagondlu Venkatesh
  • Patent number: H2213
    Abstract: The present invention generally relates to the field of plant genetics and protein biochemistry. More specifically, the present invention relates to modified proteins having an increased number of essential amino acids. The present invention provides proteins modified to have an increased number of essential amino acids, nucleic acid sequences encoding the enhanced proteins, and methods of designing, producing, and using the same. The present invention also includes compositions, transformed host cells, transgenic plants, and seeds containing the enhanced proteins, and methods for preparing and using the same.
    Type: Grant
    Filed: April 9, 2003
    Date of Patent: April 1, 2008
    Assignee: Monsanto Technology LLC
    Inventors: Tim N. Oulmassov, William D. Rapp, Kairong Tian, Jason A. Wicker, William J. Welsh, Xia Wang, Robert K. DeLisle, Tyamagondlu V. Venkatesh, Jihong Liang